Physician profile
Ward Hall
NPI 1780763706
$1,122.19
in general payments reported to CMS, 2019-2025
15 companies · $71.54 in 2025
The $71.54 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $227 · 2022: $340 · 2023: $483 · 2025: $71.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $554.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $377.16 | 2022-2023 | Stelara, Simponi Aria, Remicade |
| Evoke Pharma, INC. | $176.65 | 2021-2023 | Gimoti |
| Amgen INC. | $117.33 | 2021-2025 | Evenity, Otezla, Repatha |
| Abbvie INC. | $93.47 | 2021-2023 | |
| Lilly USA, LLC | $69.58 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $51.02 | 2023 | Rexulti |
| Pfizer INC. | $40.70 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.35 | 2022-2023 | Entyvio |
| Abbott Laboratories | $33.98 | 2021-2023 | Freestyle Libre 3 |
| Novo Nordisk INC | $28.27 | 2023 | Ozempic |
| Merck Sharp & Dohme LLC | $28.22 | 2021 | |
| Pharmacosmos Therapeutics INC. | $27.32 | 2022 | |
| Philips North America LLC | $14.43 | 2022 | |
| Daiichi Sankyo INC. | $14.30 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ward Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.